This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Eaddy M, O'Day K, Tangirala KM, Seal B.The economic implications of rasburicase treatment in adult tumor lysis syndrome patients. 45th Annual Meeting of the American Society of Clinical Oncology: abstr. e17503, 29 May 2009. Available from: URL: http://www.abstract.asco.org
O'Day K, Eaddy M, Seal B, Tangirala KM.The economic implications of rasburicase treatment in pediatric tumor lysis syndrome patients. 45th Annual Meeting of the American Society of Clinical Oncology: 531 abstr. 10050, 1 Jun 2009. Available from: URL: http://www.abstract.asco.org
Rights and permissions
About this article
Cite this article
It pays to use rasburicase for TLS. Pharmacoecon. Outcomes News 580, 9 (2009). https://doi.org/10.2165/00151234-200905800-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905800-00019